Agilent AdvanceBio Glycan Mapping column - user guide

Importance of the Topic

Glycan mapping is a critical component of biotherapeutic characterization, providing detailed information on N-linked glycosylation profiles that influence efficacy, stability and immunogenicity. High-performance hydrophilic interaction liquid chromatography (HILIC) enables sensitive, reproducible separation of fluorescently labeled glycans to support quality control, comparability studies and regulatory submissions.

Objectives and Article Overview

This guide outlines best practices for using AdvanceBio Glycan Mapping columns to analyze 2-AB and InstantPC labeled N-glycans. It reviews column operating parameters, system setup, conditioning procedures, recommended gradients for both high-resolution and high-throughput methods, safety considerations and maintenance protocols to ensure consistent performance.

Methodology and Instrumentation

The HILIC separation employs silica-based amide stationary phases in 1.8 µm (2.1 × 150 mm) or 2.7 µm (2.1 × 100 mm) formats. Key parameters include:

• Operating pressure: up to 1,200 bar (1.8 µm) or 600 bar (2.7 µm), optimal long-term use at ≤ 80 % of maximum pressure.
• Temperature range: 40 °C (high resolution) or 35 °C (high throughput), noting higher temperatures shorten column life.
• pH tolerance: 2–7 for aqueous mobile phases; avoid extended use above pH 7.
• Mobile phases: acetonitrile with 50 – 100 mM ammonium formate buffer at pH 4.4 – 4.5.
• Injection volume: 1 µL for optimal peak shape.
• Detection: fluorescence at 260/430 nm for 2-AB, 285/345 nm for InstantPC labels.

Columns must be equilibrated by sequential flushing (100 % acetonitrile, 15 % aqueous, then analysis conditions) and confirmed by multiple test runs. Samples require filtration through 0.2 µm filters to protect the inlet frit.

Main Results and Discussion

Using recommended gradients, both high-resolution (60 min) and high-throughput (5 min) methods achieve clear separation of key glycoforms such as G0F, G1F, G2F and Man5. The guide’s QC performance report demonstrates reproducibility across batches. Proper column care and solvent selection extend usable lifetime and maintain efficiency.

Benefits and Practical Applications

• Robust glycan profiling for monoclonal antibodies and glycoproteins in R&D and QC laboratories.
• Flexibility to switch between detailed structural analysis and rapid screening.
• Compatibility with fluorescence and mass spectrometry detection.
• Streamlined workflows via pre-validated column performance and provided glycan standards.

Future Trends and Opportunities

Advances may include integration of novel fluorescent or mass tags, automated sample preparation, ultra-high-pressure UHPLC formats and AI-driven data interpretation. Emerging stationary phases with improved selectivity and miniaturized HILIC systems will further accelerate glycan analysis in biopharmaceutical development.

Conclusion

AdvanceBio Glycan Mapping columns offer a validated, high-performance solution for N-glycan separation by HILIC, supporting both in-depth and high-throughput analyses. Adherence to recommended operating conditions, conditioning protocols and maintenance routines ensures reliable, reproducible glycan profiles essential for therapeutic characterization and quality control.

References

Agilent Technologies, AdvanceBio Glycan Mapping Column User Guide, May 2019.